Skip to Main Content

Paper Details

Precision Combination Therapies Based on Recurrent Oncogenic Coalterations.
Cancer Discov
16
2022
Cancer, Cancer cells, DNA repair, HER2, oncogenic coalterations, patient, tumor, tumors
Author NameAffiliation
Augustin LunaDana-Farber Cancer Institute
Augustin LunaHarvard Medical School
Scott KopetzThe University of Texas MD Anderson Cancer Center
Chris SanderDana-Farber Cancer Institute
Chris SanderHarvard Medical School
Chris SanderDana-Farber Cancer Institute
Chris SanderHarvard Medical School
  • 1 - 7

Datasets

Release 1.2